• Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Credit Suisse Lux Biotechnology Equity Fund

+ Add to Watchlist

C27B:GR

296.0800 EUR 1.3900 0.47%

As of 10:26:00 ET on 01/23/2015.

Snapshot for Credit Suisse Lux Biotechnology Equity Fund (C27B)

Open: 301.6200 High - Low: 306.1200 - 296.0800 Primary Exchange: Dusseldorf
Volume: 0 52-Week Range: 197.4300 - 306.1200 Beta vs NBI: -

ETF Chart for C27B

No chart data available.
  • C27B:GR 301.6200
  • 1D
  • 1M
  • 1Y
294.6900
Interactive C27B Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for C27B

Credit Suisse Lux Biotechnology Equity Fund is a SICAV incorporated in Luxembourg. The Fund is actively managed aiming to outperform the return of the NASDAQ Biotechnology TR benchmark. The Fund mainly invests in equity and equity-type securities of issuers engaged in the biotechnology industry.

Inception Date: Telephone: -
Managers: IRENE BEATRICE PUETTNER
Web Site: www.credit-suisse.com

Fundamentals for C27B

NAV (on 2015-01-22) 298.4600
Assets (M) (on 2015-01-22) 236.1231
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -1.26
Average 52-Week % Premium -0.8382
Fund Leveraged N

Dividends for C27B

No dividends reported

Performance for C27B

1-Month +9.40% 1-Year +23.27%
3-Month +15.16% 3-Year -
Year To Date +5.70% 5-Year +27.23%
Expense Ratio -

Top Fund Holdings for C27B

Filing Date: 10/31/2014
Name Position Value % of Total
Gilead Sciences Inc 162,484 18,198,208 8.274%
Amgen Inc 105,973 17,186,701 7.814%
Celgene Corp 160,276 17,163,957 7.803%
Biogen Idec Inc 42,745 13,724,565 6.240%
Regeneron Pharmaceuticals Inc 27,000 10,630,440 4.833%
Incyte Corp 153,000 10,260,180 4.665%
Vertex Pharmaceuticals Inc 90,000 10,137,600 4.609%
Alexion Pharmaceuticals Inc 52,752 10,094,623 4.589%
BioMarin Pharmaceutical Inc 115,444 9,524,130 4.330%
Medivation Inc 80,000 8,456,000 3.844%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil